Quizartinib
Drug timelines are a Plus or Pro feature.
35 regulatory and trial events tracked for Quizartinib, covering 2014-06-11 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome [Phase 1, Phase 2]